Choose Site

Outside Publication

Declaratory Judgments Unavoidable for Biosimilar Applicants, Law360

March 05, 2021

Associates Candace Polster and Richard Martin and partner Christopher Betti authored an article for Law360 regarding the Biologics Price Competition and Innovation Act. In the article, the authors discussed the information a biosimilar applicant must disclose under the information exchange provisions, and the judgement action applicants could face irrespective of the amount and type of information they provide to the brand holder.

Read the full Law360 article >>